Advanced search
Publication Cover
Health, Risk & Society Volume 12, 2010 - Issue 5
Submit an article Journal homepage
235
Views
7
CrossRef citations to date
0
Altmetric
Original articles: Risk advice and communication

Pharmaceutical risk communication: Sources of uncertainty and legal tools of uncertainty management

Barbara Osimani Centre of Bioethics, Università Cattolica del Sacro Cuore, Milan, ItalyCorrespondence[email protected]
Pages 453-469 | Received 10 Sep 2009, Accepted 07 Dec 2009, Published online: 05 Oct 2010

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Shelley K. White & Abigail N. Walters. (2018) Assessing risk by analogy: a case study of us medical device risk management policy. Health, Risk & Society 20:7-8, pages 358-378.
Read now
Barbara Osimani. (2013) The precautionary principle in the pharmaceutical domain: a philosophical enquiry into probabilistic reasoning and risk aversion. Health, Risk & Society 15:2, pages 123-143.
Read now
Andy Alaszewski. (2011) Drugs, risk and society: Government, governance or governmentality?. Health, Risk & Society 13:5, pages 389-396.
Read now
Courtney Davis & John Abraham. (2011) A comparative analysis of risk management strategies in European Union and United States pharmaceutical regulation. Health, Risk & Society 13:5, pages 413-431.
Read now

Articles from other publishers (3)

Yordanis Enríquez Canto & Barbara Osinami. (2015) Is genetic Information Family Property? Expanding on the Argument of Confidentiality Breach and Duty to Inform Persons at Risk. Persona y Bioética 19:1, pages 11-24.
Crossref
Barbara Osimani & Fiorenzo Mignini. (2014) Causal Assessment of Pharmaceutical Treatments: Why Standards of Evidence Should not be the Same for Benefits and Harms?. Drug Safety 38:1, pages 1-11.
Crossref
Joel J Davis. (2012) Content analysis of efficacy descriptions on branded pharmaceutical websites. Journal of Medical Marketing: Device, Diagnostic and Pharmaceutical Marketing 12:4, pages 211-220.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.